MENU
+Compare
AKRO
Stock ticker: NASDAQ
AS OF
Aug 6, 11:54 AM (EDT)
Price
$51.45
Change
+$1.89 (+3.81%)
Capitalization
3.95B

AKRO Akero Therapeutics Forecast, Technical & Fundamental Analysis

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs... Show more

AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for AKRO with price predictions
Aug 05, 2025

AKRO in upward trend: price may jump up because it broke its lower Bollinger Band on July 29, 2025

AKRO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 42 cases where AKRO's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AKRO's RSI Oscillator exited the oversold zone, of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 63 cases where AKRO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AKRO advanced for three days, in of 304 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on AKRO as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

AKRO moved below its 50-day moving average on July 24, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AKRO crossed bearishly below the 50-day moving average on July 29, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AKRO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AKRO entered a downward trend on August 05, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.577) is normal, around the industry mean (18.071). P/E Ratio (0.000) is within average values for comparable stocks, (58.287). AKRO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.533). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (278.010).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AKRO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AKRO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

AKRO is expected to report earnings to -90 cents per share on August 08

Akero Therapeutics AKRO Stock Earnings Reports
Q2'25
Est.
$-0.90
Q1'25
Beat
by $0.11
Q4'24
Beat
by $0.17
Q3'24
Missed
by $0.17
Q2'24
Beat
by $0.02
The last earnings report on May 13 showed earnings per share of -89 cents, beating the estimate of -100 cents. With 373.24K shares outstanding, the current market capitalization sits at 3.95B.
A.I. Advisor
published General Information

General Information

a biotechnology company, which specializes in transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
601 Gateway Boulevard
Phone
+1 650 487-6488
Employees
56
Web
https://www.akerotx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OIIEX14.870.03
+0.20%
Optimum International Instl
TLVAX23.93N/A
N/A
Timothy Plan Large/Mid Cap Value A
FDYNX154.69N/A
N/A
Franklin DynaTech C
EIPFX19.03N/A
N/A
EIP Growth and Income Investor
FTXCX43.46N/A
N/A
FullerThaler Behavioral Sm-Cp Gr C

AKRO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, AKRO has been loosely correlated with ETNB. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if AKRO jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKRO
1D Price
Change %
AKRO100%
+1.93%
ETNB - AKRO
60%
Loosely correlated
+3.75%
SLS - AKRO
41%
Loosely correlated
+1.89%
IDYA - AKRO
38%
Loosely correlated
-3.52%
MDGL - AKRO
37%
Loosely correlated
+8.59%
NAUT - AKRO
35%
Loosely correlated
+1.32%
More